HTB

Monkeypox

Monkeypox into Autumn: still no emergency funding, vaccine efficacy and UK declines further vaccines

Tecovirimat treatment for monkeypox in the UK: importance of the PLATINUM study

Levels of monkeypox viral load in different body sites supports highest risk from body contact

Severe complication of monkeypox reported to the US CDC: risks associated with HIV and other causes of immunosuppression

New reports on MPX vaccine efficacy suggest protection but cases reported after two shots

Other monkeypox studies of interest

BHIVA, BASHH and other professional organisations publish open letters on the refusal by the UK government to acknowledge monkeypox crisis

Featured Update on monkeypox in the UK: reduced cases, vaccine access, transmission and treatment…

Montreal’s response to monkeypox: rapid vaccine rollout, 39 breakthrough infections

Summary of 620 cases of monkeypox seen at three London clinics

US survey reports 50% of gay men changed sexual behaviour to avoid monkeypox

US model limits monkeypox infections by one-third from having fewer one-time partners: short-term strategy until next vaccine supply

BHIVA include efficacy data on HIV and monkeypox vaccine: updated statement (August 2022)

Monkeypox DNA detected in anal samples of asymptomatic men in Paris and Belgium

Unusual case reports: non-sexual acquisition, severe MPX and advanced HIV, human-to-dog transmission

Tecovirimat for treating mild monkeypox: new studies open in the UK and US

US cases: MMWR report on 1891 cases to 22 July 2022

Monkeypox transmission in heterosexual couples in Nigeria

Access to vaccines and treatment for pregnant women at risk of monkeypox

MPX DNA easily detected on surfaces in hospital after cleaning

Understanding HIV and monkeypox coinfection: NEAT/EACS dashboard

BHIVA include efficacy data on HIV and monkeypox vaccine: updated statement

Taking a break from monkeypox: four weeks out for August

WHO declares the monkeypox pandemic a global health emergency

UK organisations call for £51 million to urgently tackle monkeypox crisis

EMA approves Imvanex vaccine against monkeypox in EU

International study of 528 monkeypox (MPX) cases: results from the 2022 outbreak need to inform new management guidelines

Tecovirimat to treatment monkeypox: an urgent need for both RCT and expanded access

Monkeypox DNA detected at high levels in saliva and is common in semen and other samples

Risk of monkeypox being infectious on hard surfaces and soft materials: guidelines for effective cleaning

Outcomes of 54 cases of monkeypox (MPX) in London: fewer early symptoms but higher rates of genital lesions – urgency of funding sexual health

Ending the monkeypox outbreak through vaccination, contact tracing and early diagnosis

US doctors think it is already too late to contain monkeypox

Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride

UK offers limited vaccine to gay and bisexual men at risk of monkeypox: full dose offered in NYC

Monkeypox outbreak: Update and further information

Monkeypox cases in gay men in the UK: BHIVA and ECDC rapid statements

Monkeypox DNA in semen supports advice to use condoms for eight weeks after infection has cleared

Risk of monkeypox becoming endemic in Europe: ECDC assessment

Seven cases of monkeypox virus in the UK from 2018 to 2021

Monkeypox: Q&A factsheet